Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118)
12/2005
12/07/2005EP0912508B2 Process for preparing caprolactam from 6-aminocapronitrile
12/07/2005CN1705639A Process for the synthesis of intermediates useful for the synthesis of tubulin inhibitors
12/07/2005CN1705635A Inhibitors of histone deacetylase
12/07/2005CN1230416C Pharmaceutical compounds
12/06/2005US6972340 For therapy of diabetes, obesity, autoimmune disorders, acute and chronic inflammatory disorders, osteoporosis, cancer, malignant disorders
12/06/2005US6972300 Compounds and compositions for delivering active agents
12/06/2005US6972295 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis
12/06/2005CA2268910C Asymmetrical imide bleach activators and compositions employing the same
12/06/2005CA2206787C 2,5-diamino-3,4-disubstituted-1,6-diphenylhexane isosteres comprising benzamide, sulfonamide and anthranilamide subunits and methods of using same
12/06/2005CA2096528C Retroviral protease inhibitors
12/01/2005WO2005113582A1 Substituted ethane-1,2-diamines for the treatment of alzheimer's disease
12/01/2005WO2005113489A1 Substituted n-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathies
12/01/2005WO2005113487A2 Polyurea compositions and compounds for the preparation thereof
12/01/2005WO2005113486A1 Carboxamido opioid compounds
12/01/2005WO2005112945A2 Synthesis of tetracyclines and analogues thereof
12/01/2005US20050267215 Abca-1 elevating compounds
12/01/2005US20050267169 Watersoluble prodrugs of propofol
12/01/2005US20050267079 Tetracycline derivatives and methods of use thereof
12/01/2005US20050265951 Novel composition containing acyl group
12/01/2005DE102004023507A1 Substituierte Cyclohexylessigsäure-Derivate Cyclohexylacetic substituted derivatives
12/01/2005DE102004023506A1 Kettenverlängerte substituierte Cyclohexyl-1,4-diamin-Derivate Chain-substituted cyclohexyl-1,4-diamine derivatives
12/01/2005CA2767912A1 Synthesis of tetracyclines and analogues thereof
12/01/2005CA2567481A1 Method for producing diphenyl azetidinone derivatives
12/01/2005CA2566605A1 Polyurea compositions and compounds for the preparation thereof
12/01/2005CA2566090A1 Substituted n-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathies
11/2005
11/30/2005EP1599441A1 Process for the preparation of an alpha-amino carbonyl compound
11/30/2005EP1599432A1 Adamantane derivatives, processes for their preparation and pharmaceutical composition containing them
11/30/2005CN1703395A Aryl and heteroaryl compounds and methods to modulate coagulation
11/30/2005CN1229339C Compounds inhibiting angiogenesis and tumor growth, pharmaceutical preparation containing same and pharmaceutical use thereof
11/30/2005CN1229335C Nervinolin derivatives
11/30/2005CN1229329C Substituted amino amide salicylate with fungal killing function and its prepared intermediate thereof
11/29/2005US6969770 reacting an alpha-keto carboxy acid ester or derivative with a pyrrolidinone to form an intermediate, subjecting the intermediate to asymmetric hydrogenation using a chiral catalyst to form the end product
11/24/2005WO2005110977A1 Substituted cyclohexylcarboxylic acid derivatives
11/24/2005WO2005110976A1 Substituted cyclohexylacetic acid derivatives
11/24/2005WO2005110975A1 Substituted cyclohexyl-1,4-diamine derivatives with a chain extension
11/24/2005WO2005110973A1 Acid derivatives of substituted cyclohexyl-1,4-diamines
11/24/2005WO2005092011A3 Mitotic kinesin inhibitors
11/24/2005WO2005077884A3 Hydroaminomethylation of olefins
11/24/2005US20050261372 NMDA receptor agonist; neurodegenerative diseases, cognition activator; autism, schizophrenia, Alzheimer's disease; glycinergic and/or glutaminergic transmission activator
11/24/2005US20050261343 Anthranilamides and their use as pharmaceutical agents
11/24/2005US20050261305 Cyclic protein tyrosine kinase inhibitors
11/24/2005US20050261273 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
11/24/2005US20050261242 nitroso derivatives of drugs such as antiinflammatory agents, antibiotics, expectorants, mucolytic agents, antidiabetics, antitumor, viricides, enzyme inhibitors bronchodilators and antiulcer agents; oxidative and endothelial stress dysfunction; free radicals scavenger
11/24/2005US20050260597 Transfection reagents
11/23/2005EP1598067A1 Carbamic acid compounds comprising an amide linkage as HDAC inhibitors
11/23/2005EP1596808A2 L-dopa amide derivatives and uses thereof
11/23/2005EP1335898B1 Carbamic acid compounds comprising an amide linkage as hdac inhibitors
11/23/2005CN1700923A Multi-substituted selective androgen receptor modulators and methods of use thereof
11/23/2005CN1700922A 3, 10, and 12a substituted tetracycline compounds
11/23/2005CN1699333A Process for preparing 3,4-dihydroxy-2-amino butyric acid derivatives
11/23/2005CN1228314C Synthesis process of theancine
11/17/2005WO2005108405A2 Lanthanide chelates and use thereof in bioanalysis
11/17/2005WO2005108368A1 Adamantyl-acetamide derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
11/17/2005WO2005108347A2 Substituted enaminones, their derivatives and uses thereof
11/17/2005WO2005107762A2 Certain chemical entities, compositions, and methods
11/17/2005WO2005016264A3 Diamine derivatives of quinone and uses thereof
11/17/2005US20050256333 4-(3-(2,6-Dimethoxybenzyloxy)phenyl)-4-oxobutyric acid or derivatives for treatment of insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis or arteriosclerosis
11/17/2005US20050256203 3-[(1-RS,2-SR)-2-[(dimethylamino)methyl]-1-hydroxycyclohexyl]-benzamide; treating a central nervous system disorder; antinociceptive and analgesic potency and efficacy
11/17/2005US20050256191 Nitroaniline-based alkylating agents and their use as prodrugs
11/17/2005US20050256116 Novel biaromatic compounds which activate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof
11/17/2005US20050255138 Active agent transport systems
11/17/2005US20050255066 Organosilicone derivatives of amino hydroxybenzophenones and their use as uv-a filters in cosmetic preparations
11/17/2005CA2568241A1 Adamantyl-acetamide derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
11/17/2005CA2565695A1 Certain chemical entities and compositions for use in the treatment of a cellular proliferative disease or disorder
11/16/2005EP1594845A2 Benzene acetamide compounds useful as serine protease inhibitors
11/16/2005EP1594819A1 Irreversible caspase-3 inhibitors as active site probes
11/16/2005CN1227218C Process for preparing 6-aminocaproamide
11/15/2005US6965049 Zwitterionic lipid compound and uses thereof
11/15/2005CA2130944C Ortho-substituted benzoylguanidines, process for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them
11/10/2005WO2005105744A1 Histamine-3 receptor antagonists
11/10/2005WO2005105152A2 Lipids, lipid complexes and use thereof
11/10/2005US20050250857 Gelling agents
11/10/2005US20050250819 Inhibitors of bacterial type III protein secretion systems
11/10/2005US20050250744 Pharmaceutically active compounds and methods of use thereof
11/10/2005CA2565633A1 Lipids, lipid complexes and use thereof
11/10/2005CA2564258A1 Histamine-3 receptor antagonists
11/09/2005EP1593671A1 DPP-IV inhibitors
11/09/2005EP1592684A1 Malonamide derivatives as gamma-secretase inhibitors
11/09/2005EP1592665A2 Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity
11/09/2005EP1592653A2 MONO, DI TRI CYCLIC COMPOUNDS USEFUL FOR LOWERING IgE CONCENTRATIONS
11/09/2005EP1501787B1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists
11/09/2005EP1042275B1 Anticonvulsant and central nervous system-active bis(fluorophenyl)alkylamides
11/09/2005EP1019365B1 Novel compositions for the delivery of negatively charged molecules
11/09/2005CN1694864A N-bridged selective androgen receptor modulators and methods of use thereof
11/09/2005CN1226284C N-sulphonyl and N-sulphinyl phenylglycinamide
11/09/2005CN1226278C Recovery method of demeclocy cline hydrochloride crystal mother liquor
11/08/2005US6963010 Hydrophobic polyamine analogs and methods for their use
11/08/2005US6962934 Such as N-((2S)-2-((3-((dipropylamino)carbonyl)-benzoyl) amino)-3-phenylpropyl)-L-alanyl-N1-isobutyl-L-valinamide; secretase inhibitors
11/03/2005WO2005102988A1 Method of separately collecting optically active amino acid amide and optically active amino acid
11/03/2005WO2005080316A3 Modulators of cannabinoid receptors
11/03/2005WO2005079541A3 Terephthalamide peptidomimetic compounds and methods
11/03/2005US20050245615 Treating proliferative cutaneous disease using a polyamine acylated with a hydrophobic acyl group, where acylation is by formation of either an amide or a sulfonamide linkage; e.g. lupus; use with other biosynthesis enzyme inhibitors
11/03/2005US20050245543 Histamine-3 receptor antagonists
11/03/2005US20050245534 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
11/03/2005US20050245491 Tetracycline derivatives and methods of use thereof
11/02/2005EP1590340A1 Inhibitors of histone deacetylase
11/02/2005EP1590319A1 Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1
11/02/2005EP1242363B1 Cd45 inhibitors
11/02/2005EP1159261B1 Antizyme modulators and their use
11/02/2005EP1005493B1 Antiviral protease inhibitors
1 ... 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 ... 162